Tandem Diabetes Care (TNDM) Net Cash Flow (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Net Cash Flow came in at $89.8 million in Q1 2026, up 751.43% YoY from $10.5 million in Q1 2025, and up 3575.3% on a QoQ basis from -$2.6 million in Q4 2025.
Tandem Diabetes Care (TNDM) Net Cash Flow (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Net Cash Flow data on file, last reported at $89.8 million in Q1 2026.
- Quarterly Net Cash Flow rose 751.43% year-over-year to $89.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123.3 million (up 2470.0% YoY) and the FY2025 annual result came in at $19.8 million, up 117.21% from the prior year.
- Net Cash Flow climbed to $89.8 million in Q1 2026, from -$2.6 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $89.8 million in Q1 2026 to a low of -$50.4 million in Q3 2023.
- A 5-year average of $6.2 million and a median of $3.3 million in 2023 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 1051.86% in 2025, down 2680.52% in 2025.
- Tracing TNDM's Net Cash Flow over 5 years: stood at $47.7 million in 2022, then slumped by 144.41% to -$21.2 million in 2023, then soared by 185.11% to $18.0 million in 2024, then plunged by 114.33% to -$2.6 million in 2025, then soared by 3575.3% to $89.8 million in 2026.
- The last three Net Cash Flow figures came in at $89.8 million (Q1 2026), -$2.6 million (Q4 2025), and $27.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | -119.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -119.81 Mn |
| Jun 30, 2026 | -119.81 Mn |
| Mar 31, 2026 | 89.77 Mn |
| Mar 31, 2026 | 89.77 Mn |
| Dec 31, 2025 | -2.58 Mn |
| Dec 31, 2025 | -2.58 Mn |
| Sep 30, 2025 | 27.23 Mn |
| Sep 30, 2025 | 27.23 Mn |
| Jun 30, 2025 | 8.92 Mn |
| Jun 30, 2025 | 8.92 Mn |
| Mar 31, 2025 | -13.78 Mn |
| Mar 31, 2025 | -13.78 Mn |
| Dec 31, 2024 | 18.03 Mn |
| Dec 31, 2024 | 18.03 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | -11.82 Mn |
| Jun 30, 2024 | -11.82 Mn |
| Mar 31, 2024 | 534,000.00 |
| Mar 31, 2024 | 534,000.00 |